Biofeedback-Based Cognitive Behavioral Treatment for Temporomandibular Disorders

Summary

The purpose of this study is to develop and evaluate a biofeedback-based cognitive behavioral treatment for patients with chronic temporomandibular disorders using a randomized controlled design.

Conditions

• Temporomandibular Disorders

Interventions

BEHAVIORAL

Biofeedback-Based Cognitive Behavioral Treatment

The biofeedback-based cognitive behavioral intervention comprises 8 individual sessions, each containing both cognitive behavioral and biofeedback elements. Treatment elements are education about the disorder, biofeedback training aimed at improving proprioceptive awareness and reversing parafunctional habits, relaxation techniques, and stress management. Furthermore patients receive portable biofeedback devices for EMG-biofeedback training during day and nighttime in order to reverse diurnal and nocturnal bruxing habits.

DEVICE

Dental treatment with occlusal splint (OS)

Maxillary or mandibular occlusal splints are made of hard acrylic after taking impressions of the upper and lower dental arches, face bow registration and recording of centric relation. Splints are adjusted to provide even occlusal contact during jaw closing and chewing, and canine and incisor contact during protrusive movements of the jaw. Patients are instructed to use the splint each night and during day time for a period of 7 weeks. One week after initial insertion of the splint patients are requested to return for adjustment.

Sponsors & Collaborators

• Psychotherapie-Ambulanz Marburg e.V.

  collaborator OTHER

• Philipps University Marburg

  lead OTHER

Principal Investigators

• Winfried Rief, Prof. Dr. · Department of Clinical Psychology and Psychotherapy, Philipps University Marburg, Germany

• Gaby M Bleichhardt, Dr. (PhD) · Department of Clinical Psychology and Psychotherapy, Philipps University Marburg, Germany

• Meike C Shedden Mora, Dipl. Psych. · Department of Clinical Psychology and Psychotherapy, Philipps University Marburg, Germany

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

70 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2008-08-31

Primary Completion

2010-07-31

Completion

2011-04-30

Countries

• Germany

Study Locations